93
Participants
Start Date
June 30, 2010
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
Investigational new drug, company code: BGG492
Placebo
Investigational new drug, company code: BGG492
Novartis Investigative Site, Taipei
Novartis Investigative Site, Budapest
Novartis Investigative Site, Sofia
Novartis Investigative Site, Bern
Novartis Investigative Site, Aarau
Novartis Investigative Site, Kecskemét
Novartis Investigative Site, Zurich
Novartis Investigative Site, Szombathely
NYU Comprehensive Epilepsy Center, New York
Novartis Investigative Site, Bernau
Thomas Jefferson University, Dept. of Psychiatry & Neurology, Philadelphia
Novartis Investigative Site, Milan
Johns Hopkins Hospital, Baltimore
Novartis Investigative Site, Venezia
AMO Corporation, Tallahassee
Novartis Investigative Site, Lin-ko
Novartis Investigative Site, Bielefeld
Investigative Site - Private Practice, Ocean Springs
Novartis Investigative Site, Bologna
Novartis Investigative Site, Milan
Novartis Investigative Site, Florence
Novartis Investigative Site, Bonn
St.John's Research Institute, Inc, Springfield
Novartis Investigative Site, Tübingen
Clinical Trials, Inc., Little Rock
Neurological Clinic of Texas, Dallas
Novartis Investigative Site, Kehl-Kork
Novartis Investigative Site, Napoli
Medical Center of the Rockies, Loveland
Barrow Neurological Clinics at St. Joseph's Hospital and MC, Phoenix
Center for Neurosciences, Tucson
Novartis Investigative Site, Catanzaro
Renown Institute for Neurosciences, Reno
NJ to Capital Health in Hamilton, Somerset
Princeton and Rutgers Neurology, Somerset
Novartis Investigative Site, Marburg
Novartis Investigative SIte, Regensburg
Novartis Investigative Site, Ulm
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Changhua
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Taipei
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Krakow
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Banská Bystrica
Novartis Investigative Site, Košice
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Lead Sponsor
Novartis
INDUSTRY